Xue Yali, Daly Allan, Yngvadottir Bryndis, Liu Mengning, Coop Graham, Kim Yuseob, Sabeti Pardis, Chen Yuan, Stalker Jim, Huckle Elizabeth, Burton John, Leonard Steven, Rogers Jane, Tyler-Smith Chris
The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambs CB10 1SA, United Kingdom.
Am J Hum Genet. 2006 Apr;78(4):659-70. doi: 10.1086/503116. Epub 2006 Feb 21.
The human caspase-12 gene is polymorphic for the presence or absence of a stop codon, which results in the occurrence of both active (ancestral) and inactive (derived) forms of the gene in the population. It has been shown elsewhere that carriers of the inactive gene are more resistant to severe sepsis. We have now investigated whether the inactive form has spread because of neutral drift or positive selection. We determined its distribution in a worldwide sample of 52 populations and resequenced the gene in 77 individuals from the HapMap Yoruba, Han Chinese, and European populations. There is strong evidence of positive selection from low diversity, skewed allele-frequency spectra, and the predominance of a single haplotype. We suggest that the inactive form of the gene arose in Africa approximately 100-500 thousand years ago (KYA) and was initially neutral or almost neutral but that positive selection beginning approximately 60-100 KYA drove it to near fixation. We further propose that its selective advantage was sepsis resistance in populations that experienced more infectious diseases as population sizes and densities increased.
人类半胱天冬酶 - 12基因存在多态性,即存在或不存在终止密码子,这导致该基因在人群中同时存在活性(原始)和无活性(衍生)形式。其他地方已经表明,无活性基因的携带者对严重脓毒症更具抵抗力。我们现在研究了无活性形式的基因是由于中性漂变还是正选择而传播开来的。我们确定了它在全球52个群体样本中的分布,并对来自国际人类基因组单体型图计划(HapMap)的约鲁巴人、汉族人和欧洲人群体的77个人的该基因进行了重新测序。从低多样性、偏态等位基因频率谱以及单一单倍型的优势等方面有强有力的证据表明存在正选择。我们认为该基因的无活性形式大约在10万至50万年前出现在非洲,最初是中性或几乎中性的,但大约在6万至10万年前开始的正选择使其几乎固定下来。我们进一步提出,其选择优势在于随着人口规模和密度增加而经历更多传染病的人群中的脓毒症抗性。